SOWAHD
gene geneOn this page
Summary
SOWAHD (sosondowah ankyrin repeat domain family member D, HGNC:32960) is a protein-coding gene on chromosome Xq24, encoding Ankyrin repeat domain-containing protein SOWAHD (A6NJG2).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 27 total
- MANE Select transcript:
NM_001105576
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32960 |
| Approved symbol | SOWAHD |
| Name | sosondowah ankyrin repeat domain family member D |
| Location | Xq24 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000187808 |
| Ensembl biotype | protein_coding |
| Entrez | 347454 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000343905
RefSeq mRNA: 1 — MANE Select: NM_001105576
NM_001105576
CCDS: CCDS43984
Canonical transcript exons
ENST00000343905 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001388439 | 119758588 | 119760202 |
Expression profiles
Bgee: expression breadth ubiquitous, 114 present calls, max score 80.65.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5792 / max 43.1011, expressed in 211 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197404 | 0.4458 | 158 |
| 197403 | 0.1334 | 50 |
Top tissues by expression
125 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 80.65 | gold quality |
| leukocyte | CL:0000738 | 79.20 | gold quality |
| monocyte | CL:0000576 | 79.12 | gold quality |
| blood | UBERON:0000178 | 77.84 | gold quality |
| spleen | UBERON:0002106 | 73.92 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 69.68 | gold quality |
| placenta | UBERON:0001987 | 69.56 | gold quality |
| lymph node | UBERON:0000029 | 67.46 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 67.08 | gold quality |
| duodenum | UBERON:0002114 | 66.54 | gold quality |
| bone marrow cell | CL:0002092 | 66.19 | silver quality |
| bone marrow | UBERON:0002371 | 66.05 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 64.32 | gold quality |
| vermiform appendix | UBERON:0001154 | 64.05 | gold quality |
| right testis | UBERON:0004534 | 63.85 | gold quality |
| small intestine | UBERON:0002108 | 63.64 | gold quality |
| left testis | UBERON:0004533 | 63.57 | gold quality |
| testis | UBERON:0000473 | 63.26 | gold quality |
| right lung | UBERON:0002167 | 59.20 | gold quality |
| tonsil | UBERON:0002372 | 58.29 | gold quality |
| transverse colon | UBERON:0001157 | 58.00 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 55.87 | gold quality |
| body of stomach | UBERON:0001161 | 55.75 | gold quality |
| right coronary artery | UBERON:0001625 | 54.71 | gold quality |
| intestine | UBERON:0000160 | 53.86 | gold quality |
| stomach | UBERON:0000945 | 53.72 | gold quality |
| lung | UBERON:0002048 | 53.62 | gold quality |
| fundus of stomach | UBERON:0001160 | 53.44 | gold quality |
| right uterine tube | UBERON:0001302 | 53.27 | gold quality |
| rectum | UBERON:0001052 | 52.67 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting SOWAHD, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-299-5P | 98.56 | 71.14 | 1140 |
| HSA-MIR-6509-3P | 98.32 | 67.33 | 1343 |
| HSA-MIR-3664-3P | 97.85 | 67.62 | 1452 |
| HSA-MIR-4639-3P | 97.54 | 67.12 | 787 |
| HSA-MIR-4436B-5P | 96.71 | 68.37 | 1346 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sowahd | ENSDARG00000087152 |
| mus_musculus | Sowahd | ENSMUSG00000044400 |
| rattus_norvegicus | Sowahd | ENSRNOG00000049392 |
Paralogs (3): SOWAHB (ENSG00000186212), SOWAHC (ENSG00000198142), SOWAHA (ENSG00000198944)
Protein
Protein identifiers
Ankyrin repeat domain-containing protein SOWAHD — A6NJG2 (reviewed: A6NJG2)
Alternative names: Ankyrin repeat domain-containing protein 58, Protein sosondowah homolog D
All UniProt accessions (1): A6NJG2
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the SOWAH family.
RefSeq proteins (1): NP_001099046* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
Pfam: PF12796
UniProt features (6 total): repeat 3, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NJG2-F1 | 66.17 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 19 (showing top):
GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3, MARTENS_TRETINOIN_RESPONSE_UP, chrXq24, ZNF513_TARGET_GENES, MIR4436B_5P, DESCARTES_FETAL_CEREBRUM_MICROGLIA, DESCARTES_FETAL_HEART_MYELOID_CELLS, DESCARTES_FETAL_KIDNEY_MYELOID_CELLS, DESCARTES_FETAL_LUNG_MYELOID_CELLS, DESCARTES_FETAL_PANCREAS_MYELOID_CELLS, DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS, NFXL1_TARGET_GENES, MYOCD_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
492 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SOWAHD | ZBTB41 | Q5SVQ8 | 580 |
| SOWAHD | EIF3CL | B5ME19 | 518 |
| SOWAHD | CAMSAP2 | Q08AD1 | 379 |
| SOWAHD | KCNT2 | Q6UVM3 | 359 |
| SOWAHD | OVGP1 | Q12889 | 355 |
| SOWAHD | FRY | Q5TBA9 | 324 |
| SOWAHD | TMEM119 | Q4V9L6 | 323 |
| SOWAHD | SAMD10 | Q9BYL1 | 323 |
| SOWAHD | WDR38 | Q5JTN6 | 309 |
| SOWAHD | KNOP1 | Q1ED39 | 305 |
| SOWAHD | USP44 | Q9H0E7 | 302 |
| SOWAHD | ANKRD18A | Q8IVF6 | 300 |
| SOWAHD | ANKRD36B | Q8N2N9 | 300 |
| SOWAHD | FAM133B | Q5BKY9 | 294 |
| SOWAHD | LTB4R2 | Q9NPC1 | 290 |
IntAct
1 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| lpqN | SOWAHD | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A0U1RQ45, A0A0U1RQS6, A0A2R8YCJ5, A2A699, A2AEV7, A6NGB7, A6NJG2, A6NKF7, A6NKL6, A6NL88, A8MVW0, A9JSM3, B2RU40, B8ZZ34, C9JH25, D4A9R4, J3QNX5, P0CG09, P98077, Q0VD38, Q14761, Q17QH7, Q29RK8, Q2KJ18, Q2M3V2, Q3SX20, Q5BJT1, Q5HZJ5, Q5RKR3, Q5T442, Q64697, Q69YZ2, Q6PB97, Q6PCT2, Q6UXK2, Q6ZMQ8, Q6ZVH7, Q6ZW31, Q80XF7, Q8BLS7
Diamond homologs: A6NEL2, A6NJG2, Q2M3V2, Q53LP3, Q6NRK3, Q7XHR2, Q8BLS7, Q8BY98, Q8BZW2, Q8C0J6, Q9Z2F6, O90760
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
27 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
148 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:119759511:A:T | donor_gain | 0.7100 |
| X:119758778:T:TA | donor_gain | 0.5400 |
| X:119758779:A:AA | donor_gain | 0.5400 |
| X:119759245:TGGCG:T | acceptor_gain | 0.5400 |
| X:119759246:GGCGG:G | acceptor_gain | 0.5400 |
| X:119759272:TCATC:T | donor_gain | 0.5200 |
| X:119759481:G:GG | donor_gain | 0.5100 |
| X:119759480:A:AG | donor_gain | 0.5000 |
| X:119759601:TTCCA:T | acceptor_loss | 0.4900 |
| X:119759602:TCCAG:T | acceptor_loss | 0.4900 |
| X:119759603:CCA:C | acceptor_loss | 0.4900 |
| X:119759604:CA:C | acceptor_loss | 0.4900 |
| X:119759605:A:AT | acceptor_loss | 0.4900 |
| X:119759248:CGG:C | acceptor_gain | 0.4800 |
| X:119759562:GC:G | donor_gain | 0.4800 |
| X:119759369:G:GT | donor_gain | 0.4700 |
| X:119759560:TG:T | donor_gain | 0.4600 |
| X:119759561:GG:G | donor_gain | 0.4600 |
| X:119758787:C:T | donor_gain | 0.4400 |
| X:119759605:A:AG | acceptor_gain | 0.4300 |
| X:119759606:G:GG | acceptor_gain | 0.4300 |
| X:119759397:G:GT | donor_gain | 0.4200 |
| X:119759398:A:T | donor_gain | 0.4200 |
| X:119759606:GGACC:G | acceptor_gain | 0.4200 |
| X:119759373:T:TA | donor_gain | 0.4100 |
| X:119759587:ATCT:A | acceptor_loss | 0.4100 |
| X:119759600:A:AG | acceptor_gain | 0.4100 |
| X:119759402:G:GT | donor_gain | 0.4000 |
| X:119759510:G:GT | donor_gain | 0.4000 |
| X:119759541:G:GT | donor_gain | 0.3900 |
AlphaMissense
1992 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:119759138:G:C | K157N | 0.997 |
| X:119759138:G:T | K157N | 0.997 |
| X:119759134:C:A | A156D | 0.994 |
| X:119759320:A:T | D218V | 0.992 |
| X:119759016:T:A | W117R | 0.989 |
| X:119759016:T:C | W117R | 0.989 |
| X:119759143:G:T | G159V | 0.989 |
| X:119759127:T:A | W154R | 0.988 |
| X:119759127:T:C | W154R | 0.988 |
| X:119759236:C:A | P190H | 0.988 |
| X:119759321:C:A | D218E | 0.988 |
| X:119759321:C:G | D218E | 0.988 |
| X:119759158:T:C | L164P | 0.987 |
| X:119759248:C:A | A194E | 0.987 |
| X:119759136:A:G | K157E | 0.986 |
| X:119759239:T:A | L191H | 0.986 |
| X:119759320:A:C | D218A | 0.986 |
| X:119759329:G:T | G221V | 0.986 |
| X:119759098:A:G | D144G | 0.985 |
| X:119759129:G:C | W154C | 0.985 |
| X:119759129:G:T | W154C | 0.985 |
| X:119759133:G:C | A156P | 0.985 |
| X:119759251:C:A | A195D | 0.985 |
| X:119759319:G:C | D218H | 0.985 |
| X:119759245:T:C | L193P | 0.984 |
| X:119759242:A:G | H192R | 0.983 |
| X:119759029:C:A | A121D | 0.982 |
| X:119759241:C:G | H192D | 0.982 |
| X:119759250:G:C | A195P | 0.982 |
| X:119759131:T:C | L155P | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1002114254 (X:119759240 C>T), RS1002710021 (X:119757511 T>C), RS1003288219 (X:119759595 C>A,T), RS1005787973 (X:119760017 A>C), RS1006004447 (X:119759736 C>G), RS1006340911 (X:119760220 T>C), RS1006562957 (X:119758023 T>A,C), RS1007204296 (X:119758311 C>T), RS1009588787 (X:119756942 C>A), RS1009643179 (X:119760498 G>C,T), RS1011059681 (X:119758763 G>T), RS1013308638 (X:119757399 C>T), RS1013841914 (X:119760325 C>T), RS1015260703 (X:119757677 A>G), RS1015434195 (X:119757534 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002385_594 | High light scatter reticulocyte count | 3.000000e-09 |
| GCST90002386_506 | High light scatter reticulocyte percentage of red cells | 6.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, affects methylation, decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| mono-(2-ethylhexyl)phthalate | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| nutlin 3 | increases expression, affects cotreatment | 1 |
| licochalcone B | increases expression | 1 |
| bisphenol S | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.